Skip to main content

Published locations for Nivolumab plus Ipilumumab in NSCLC: A New Use for Tumor Mutational Burden?

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Nivolumab plus Ipilumumab in NSCLC: A New Use for Tumor Mutational Burden?

User login

  • Reset your password
  • /content/nivolumab-plus-ipilumumab-nsclc-new-use-tumor-mutational-burden
  • /jcomjournal/article/166009/oncology/nivolumab-plus-ipilumumab-nsclc-new-use-tumor-mutational-burden